(Q48017083)

7 February 2018

title

SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours (English)

1 reference

7 February 2018

author

Jason L. Hornick

series ordinal

2

1 reference

7 February 2018

author name string

James R Conner

series ordinal

1

1 reference

7 February 2018

publication date

23 May 2013

1 reference

7 February 2018

published in

Histopathology

1 reference

7 February 2018

volume

63

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

36-49

1 reference

7 February 2018

Appraising the current role of chemotherapy for the treatment of sarcoma

cites work

1 reference

Use of chemotherapy for patients with bone and soft-tissue sarcomas

21 January 2018

1 reference

Cell adhesion molecule 1 is a new osteoblastic cell adhesion molecule and a diagnostic marker for osteosarcoma

21 January 2018

1 reference

Plasma membrane proteomic analysis of human osteosarcoma and osteoblastic cells: revealing NDRG1 as a marker for osteosarcoma

21 January 2018

1 reference

Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines

21 January 2018

1 reference

Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors

21 January 2018

1 reference

Regulators of skeletal development: a cluster analysis of 206 bone tumors reveals diagnostically useful markers

21 January 2018

1 reference

A cross-species analysis of Satb2 expression suggests deep conservation across vertebrate lineages

21 January 2018

1 reference

SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation

21 January 2018

1 reference

Identification of SATB2 as the cleft palate gene on 2q32-q33.

21 January 2018

1 reference

Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects.

21 January 2018

1 reference

Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome

21 January 2018

1 reference

4.5 Mb microdeletion in chromosome band 2q33.1 associated with learning disability and cleft palate.

21 January 2018

1 reference

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

21 January 2018

1 reference

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer

21 January 2018

1 reference

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

21 January 2018

1 reference

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone

21 January 2018

1 reference

Treatment of clinically localized Ewing's sarcoma with radiotherapy and combination chemotherapy

21 January 2018

1 reference

Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial

21 January 2018

1 reference

Dedifferentiated central chondrosarcoma.

21 January 2018

1 reference

Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation

21 January 2018

1 reference

Signaling and transcriptional regulation in osteoblast commitment and differentiation

21 January 2018

1 reference

Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases

21 January 2018

1 reference

Human giant cell tumors of bone identification and characterization of cell types

21 January 2018

1 reference

Histogenetic characterization of giant cell tumor of bone

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12138

1 reference

7 February 2018

1 reference

7 February 2018